Research
Hormonal
Endurance exercise significantly increases circulating beta-hydroxybutyrate (BHBA), which acts as a signaling molecule that inhibits histone deacetylases (HDACs) and activates the HCA2 receptor, promoting anti-inflammatory and neuroprotective effects.
Endurance exercise naturally boosts BHBA, which helps protect your brain and reduce inflammation. You don't need to force a ketogenic diet to get these benefits; regular aerobic activity is sufficient to trigger this protective signaling pathway.
GoodSupportsHIGH confidence
The ketone BHBA is the most abundantly increased metabolite (AUC) following EE... Mechanistically, the benefits of BHBA on cellular health might involve a BHBA-mediated inhibition of neuronal HDACs (Shimazu et al., 2013) and/or activation of the receptor HCA2 (GPR109) (Husted et al., 2017).
Why this rating
Strong metabolomic data on BHBA levels combined with cited mechanistic literature on its downstream effects.
Source
Plasma Metabolome Profiling of Resistance Exercise and Endurance Exercise in Humans
Thomas Morville et al. · Cell Reports · 2020
DOI 10.1016/j.celrep.2020.108554
crossover · n=10Cited 167×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Acute resistance exercise and endurance exercise produce distinct, mode-specific plasma metabolomic signatures, with resistance exercise preferentially increasing nucleotide breakdown products and lactate, while endurance exercise preferentially increasing lipid metabolites and ketone bodies.Good
- Resistance exercise preferentially increases circulating lactate and purine metabolites (inosine, hypoxanthine, xanthine) compared to endurance exercise, suggesting a higher demand for glycolytic ATP turnover and nucleotide degradation during anaerobic efforts.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →